| Literature DB >> 30787400 |
Kevin A Hope1,2, Addison McGinn3, Lawrence T Reiter4,5,6.
Abstract
The genetics underlying autism spectrum disorder (ASD) are complex. Approximately 3-5% of ASD cases arise from maternally inherited duplications of 15q11.2-q13.1, termed Duplication 15q syndrome (Dup15q). 15q11.2-q13.1 includes the gene UBE3A which is believed to underlie ASD observed in Dup15q syndrome. UBE3A is an E3 ubiquitin ligase that targets proteins for degradation and trafficking, so finding UBE3A substrates and interacting partners is critical to understanding Dup15q ASD. In this study, we take an unbiased genetics approach to identify genes that genetically interact with Dube3a, the Drosophila melanogaster homolog of UBE3A. We conducted an enhancer/suppressor screen using a rough eye phenotype produced by Dube3a overexpression with GMR-GAL4. Using the DrosDel deficiency kit, we identified 3 out of 346 deficiency lines that enhanced rough eyes when crossed to two separate Dube3a overexpression lines, and subsequently identified IA2, GABA-B-R3, and lola as single genes responsible for rough eye enhancement. Using the FlyLight GAL4 lines to express uas-Dube3a + uas-GFP in the endogenous lola pattern, we observed an increase in the GFP signal compared to uas-GFP alone, suggesting a transcriptional co-activation effect of Dube3a on the lola promoter region. These findings extend the role of Dube3a/UBE3A as a transcriptional co-activator, and reveal new Dube3a interacting genes.Entities:
Year: 2019 PMID: 30787400 PMCID: PMC6382765 DOI: 10.1038/s41598-019-38663-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Fly lines used in the enhancer/suppressor screen to identify single genes acting as enhancers/suppressors of the rough eye phenotype.
| Primary Screen | Secondary Screen | Tertiary Screen | Gene Identified |
|---|---|---|---|
|
| |||
|
| |||
|
| |||
Primary screen indicates the initial DrosDel deficiency line identified as an enhancer. Secondary screen indicates lines used to narrow the genes located within the identified region, followed by tertiary screen lines if necessary. The genes identified as enhancers are listed in the right most column. (+) indicates rough eye enhancement, (−) indicates no effect.
Figure 1Identification of enhancers of the rough eye phenotype generated by Dube3a overexpression with GMR-GAL4. The first column represents control fly eyes, indicating the mild rough eye phenotype generated with GMR > Dube3a45 (A) and the severe rough eye phenotype with GMR > Dube3a27 (E). Columns 2–4 are representative images of eyes of the enhancement observed with GABA-B-R3-RNAi (B,F), IA2-RNAi (C,G), and lola-RNAi (D,H), respectively. Note the increase in necrosis observed in the RNAi lines crossed to GMR > Dube3a27 (E–H). No rough eye phenotypes were observed with the GMR > TRiP-Control line or any uas-RNAi line alone (I–L).
Figure 2Increased expression of the GFP reporter in 49389-lola > GFP + Dube3a flies. (A) Expression of the GFP reporter with 49389-lola > GFP revealed a relatively diffuse expression pattern throughout the fly optic lobe with some expression in the mushroom body (left). In 49389-lola > GFP + Dube3a flies we observed a dramatic increase in GFP levels, particularly cells in the optic lobe (right). (B) Expression of the GFP reporter with or without Dube3a in the pattern of GABA-B-R3 with 39924-GABA-B-R3-GAL4 revealed no observable differences between GFP alone (left) and GFP + Dube3a (right). Scale bar is 100 µm.